Immunohistochemical CD20-negative change in B-cell non-Hodgkin lymphomas after rituximab-containing therapy

Maeshima, AM; Taniguchi, H; Fujino, T; Saito, Y; Ito, Y; Hatta, S; Yuda, S; Makita, S; Fukuhara, S; Munakata, W; Suzuki, T; Maruyama, D; Izutsu, K

Maeshima, AM (corresponding author), Natl Canc Ctr, Dept Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

ANNALS OF HEMATOLOGY, 2020; 99 (9): 2141

Abstract

CD20(-) change after rituximab-containing therapy is considered one of the main reasons of rituximab resistance of B-cell non-Hodgkin lymphomas (B-NHL......

Full Text Link